GELS - Gelteq Limited Ordinary Shares
Gelteq Limited Ordinary Shares Logo

GELS - Gelteq Limited Ordinary Shares

https://www.gelteq.com
Recent News
Powered by Alpha Vantage
Bullish
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - Gelteq ( NASDAQ:GELS ) , Healthy Extracts ( OTC:HYEX )
Benzinga • 3 days, 4 hours ago • score: 0.18
MELBOURNE, Australia, Sept. 12, 2025 ( GLOBE NEWSWIRE ) -- Gelteq Limited ( ( "Gelteq" or the "Company, NASDAQ:GELS ) , a clinical and science-based developer of gel-based oral delivery solutions, welcomes the recently announced product launches of Healthy Extracts, Inc. ( ( "Healthy Extracts, ...
Bullish
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - Gelteq ( NASDAQ:GELS )
Benzinga • 1 month, 4 weeks ago • score: 0.35
NEW YORK, July 17, 2025 ( GLOBE NEWSWIRE ) -- Gelteq Limited ( "Gelteq" or the "Company" ) , a clinical and science-based company focused on developing and commercializing white label ingestible gel-based solutions for prescription drugs, nutraceuticals, pet care, sports and other products, ...
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. The company is headquartered in Caulfield, Australia.

52W High
$5.50
52W Low
$0.77

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
As of 2024-09-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
41.40
P/B (<3 favorable)
1.27
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
56.81%
Institutions (25–75% balanced)
1.06%
Shares Outstanding
10,028,000
Float
4,261,800
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2024-09-30 (Overview)
Revenue (TTM)
377,850
Gross Profit (TTM)
202,760
EPS (TTM)
-0.35
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-6.57%
ROE (TTM) (>15% strong)
-0.21%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
3.05
Momentum
Value
N/A
Previous
N/A
Trend
Signal Cross
No cross

As of